Checkpoint kinase 1 in DNA damage response and cell cycle regulation
暂无分享,去创建一个
Mallikarjun Patil | Zheng Dong | Z. Dong | Mallikarjun Patil | Navjotsingh Pabla | N. Pabla | Zheng Dong | Navjotsingh Pabla
[1] M. Blagosklonny. Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs , 2002, Oncogene.
[2] L. Karnitz,et al. The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. , 2007, Genes & development.
[3] Stephen J. Elledge,et al. Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes , 2003, Science.
[4] N. Mailand,et al. Centrosome-associated Chk1 prevents premature activation of cyclin-B–Cdk1 kinase , 2004, Nature Cell Biology.
[5] A. D’Andrea,et al. Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway , 2007, Molecular and Cellular Biology.
[6] L. Zou,et al. Chk1 and Claspin potentiate PCNA ubiquitination. , 2008, Genes & development.
[7] Yun Dai,et al. New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network , 2010, Clinical Cancer Research.
[8] F. Rosselli,et al. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia. , 2008, Human molecular genetics.
[9] O. Sansom,et al. Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis , 2012, Oncogene.
[10] Y. Sánchez,et al. U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint , 2009, Journal of Cellular and Molecular Medicine.
[11] Kathleen Marchal,et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas. , 2007, Cancer research.
[12] A. Millar,et al. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. , 2002, Cancer research.
[13] M. Broggini,et al. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. , 1999, Genes, chromosomes & cancer.
[14] M. O'Connell,et al. Regulation of Chk1 by its C-terminal domain. , 2008, Molecular biology of the cell.
[15] Jiabin Tang,et al. Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1) , 2006, Proceedings of the National Academy of Sciences.
[16] Haiying Zhang,et al. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics , 2005, International journal of cancer.
[17] M. Roberge,et al. Targeting DNA Checkpoint Kinases in Cancer Therapy , 2003, Cancer Biology & Therapy.
[18] Y. A. Minamishima,et al. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. , 2000, Genes & development.
[19] S. Elledge,et al. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.
[20] 葛城 美徳. Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation , 2004 .
[21] J. R. Hutchins,et al. Substrate specificity determinants of the checkpoint protein kinase Chk1 , 2000, FEBS letters.
[22] A. Carr,et al. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice , 2000, Current Biology.
[23] Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition , 2012, Cancer Cell International.
[24] Daigo Inoue,et al. Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism , 2004, The EMBO journal.
[25] J. Bartek,et al. DNA damage checkpoints: from initiation to recovery or adaptation. , 2007, Current opinion in cell biology.
[26] P. Nurse. A Long Twentieth Century of the Cell Cycle and Beyond , 2000, Cell.
[27] C. Cordon-Cardo,et al. p73α Regulation by Chk1 in Response to DNA Damage , 2003, Molecular and Cellular Biology.
[28] C. Prives,et al. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. , 2004, Genes & development.
[29] A. Lehmann,et al. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. , 2004, Molecular cell.
[30] J. Rosen,et al. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis , 2009, Proceedings of the National Academy of Sciences of the United States of America.
[31] H. Piwnica-Worms,et al. ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1 , 2001, Molecular and Cellular Biology.
[32] A. Kumagai,et al. The Rad9-Hus1-Rad1 Checkpoint Clamp Regulates Interaction of TopBP1 with ATR* , 2007, Journal of Biological Chemistry.
[33] D. Gillespie,et al. Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity , 2009, Oncogene.
[34] R. Poon,et al. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. , 2008, Frontiers in bioscience : a journal and virtual library.
[35] R. Abraham,et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. , 2005, Molecular cell.
[36] D. Kellogg,et al. Grapes(Chk1) prevents nuclear CDK1 activation by delaying cyclin B nuclear accumulation , 2008, The Journal of cell biology.
[37] A. Kumagai,et al. The Xenopus Chk1 Protein Kinase Mediates a Caffeine-sensitive Pathway of Checkpoint Control in Cell-free Extracts , 1998, The Journal of cell biology.
[38] M. Broggini,et al. Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer. , 1999, Oncology research.
[39] J. Bartek,et al. Human Tousled like kinases are targeted by an ATM‐ and Chk1‐dependent DNA damage checkpoint , 2003, The EMBO journal.
[40] C. Vaziri,et al. The Chk1-mediated S-phase Checkpoint Targets Initiation Factor Cdc45 via a Cdc25A/Cdk2-independent Mechanism* , 2006, Journal of Biological Chemistry.
[41] O. Bachs,et al. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells. , 2006, Cancer research.
[42] J. Bartek,et al. Inhibition of Human Chk1 Causes Increased Initiation of DNA Replication, Phosphorylation of ATR Targets, and DNA Breakage , 2005, Molecular and Cellular Biology.
[43] A. Levitzki,et al. Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents , 2010, Oncogene.
[44] Y. Shann,et al. Cloning and Characterization of Liver-specific Isoform of Chk1 Gene from Rat* , 2001, The Journal of Biological Chemistry.
[45] W. Earnshaw,et al. Chk1 is required for spindle checkpoint function. , 2007, Developmental cell.
[46] W. Sullivan,et al. The Drosophila maternal-effect mutation grapes causes a metaphase arrest at nuclear cycle 13. , 1994, Development.
[47] P. Nurse,et al. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation , 1997, The EMBO journal.
[48] Sonnet J. H. Arlander,et al. Dial 9-1-1 for DNA damage: the Rad9-Hus1-Rad1 (9-1-1) clamp complex. , 2004, DNA repair.
[49] M. Inagaki,et al. 14‐3‐3γ mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage , 2010, The EMBO journal.
[50] M. Washington,et al. Structure of Monoubiquitinated PCNA and Implications for Translesion Synthesis and DNA Polymerase Exchange , 2010, Nature Structural &Molecular Biology.
[51] P. O'Connor,et al. The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation. , 2001, Cell.
[52] N. Mailand,et al. Rapid destruction of human Cdc25A in response to DNA damage. , 2000, Science.
[53] Robert E. Johnson,et al. Eukaryotic translesion synthesis DNA polymerases: specificity of structure and function. , 2005, Annual review of biochemistry.
[54] Jiri Bartek,et al. Targeting the checkpoint kinases: chemosensitization versus chemoprotection , 2004, Nature Reviews Cancer.
[55] D. Baltimore,et al. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. , 2000, Genes & development.
[56] M. O'Connell,et al. Regulation of Chk1 , 2009, Cell Division.
[57] C. Deng,et al. Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53 , 2010, Oncogene.
[58] D. Green,et al. Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3 , 2008, Cell.
[59] Y. Higami,et al. DNA damage‐induced CHK1 autophosphorylation at Ser296 is regulated by an intramolecular mechanism , 2012, FEBS letters.
[60] Jiri Bartek,et al. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair , 2005, Nature Cell Biology.
[61] K. Cimprich,et al. ATR: an essential regulator of genome integrity , 2008, Nature Reviews Molecular Cell Biology.
[62] M. Kastan,et al. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.
[63] J. Rosen,et al. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. , 2004, Cancer cell.
[64] Shuang Huang,et al. ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis* , 2008, Journal of Biological Chemistry.
[65] Scott Davey,et al. Fission yeast chkl protein kinase links the rad checkpoint pathway to cdc2 , 1993, Nature.
[66] Jiri Bartek,et al. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks , 2006, Nature Cell Biology.
[67] A. Sancar,et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.
[68] W. Sullivan,et al. The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity , 1997, Current Biology.
[69] P. Jeggo,et al. ATR‐dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling , 2006, The EMBO journal.
[70] A. Cuddihy,et al. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells , 2001, Oncogene.
[71] N. Walworth,et al. Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest , 2002, Journal of Cell Science.
[72] H. Lieberman. DNA damage repair and response proteins as targets for cancer therapy. , 2008, Current medicinal chemistry.
[73] Stephen J. Elledge,et al. Cell Cycle Checkpoints: Preventing an Identity Crisis , 1996, Science.
[74] J. Bartek,et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. , 2003, Cancer cell.
[75] E. Nam,et al. ATR signalling: more than meeting at the fork. , 2011, The Biochemical journal.
[76] S. Elledge,et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.
[77] D. Gillespie,et al. Chk1 regulates the density of active replication origins during the vertebrate S phase , 2007, The EMBO journal.
[78] Sebastian A. Wagner,et al. A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1 , 2011, Genome Biology.
[79] M. Meuth,et al. ATR and Chk1 Suppress a Caspase-3–Dependent Apoptotic Response Following DNA Replication Stress , 2009, PLoS genetics.
[80] T. Hunter,et al. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. , 2009, Molecular cell.
[81] A. Kumagai,et al. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. , 2000, Molecular cell.
[82] R. Fishel,et al. hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced Apoptosis* , 2011, The Journal of Biological Chemistry.
[83] M. Pruschy,et al. Potentiation of DNA-damage-induced cytotoxicity by G2 checkpoint abrogators. , 2003, Current medicinal chemistry. Anti-cancer agents.
[84] K. Bhatt,et al. Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints , 2011, Proceedings of the National Academy of Sciences.
[85] Sonnet J. H. Arlander,et al. Hsp90 Inhibition Depletes Chk1 and Sensitizes Tumor Cells to Replication Stress* , 2003, Journal of Biological Chemistry.
[86] Makoto Nakanishi,et al. Chk1 Is a Histone H3 Threonine 11 Kinase that Regulates DNA Damage-Induced Transcriptional Repression , 2008, Cell.
[87] Ji-Hoon Lee,et al. ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex , 2005, Science.
[88] A. Kumagai,et al. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. , 2001, Molecular biology of the cell.
[89] T. T. Su,et al. Regulation of mitosis in response to damaged or incompletely replicated DNA require different levels of Grapes (Drosophila Chk1) , 2005, Journal of Cell Science.
[90] Jiri Bartek,et al. Chk1 and Chk2 kinases in checkpoint control and cancer. , 2003, Cancer cell.
[91] J Wade Harper,et al. The DNA damage response: ten years after. , 2007, Molecular cell.
[92] R. Syljuåsen,et al. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication , 2011, Nucleic acids research.
[93] T. Helleday,et al. Chk1 promotes replication fork progression by controlling replication initiation , 2010, Proceedings of the National Academy of Sciences.
[94] Jun Qin,et al. ATR and ATRIP: Partners in Checkpoint Signaling , 2001, Science.
[95] C. Peng,et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. , 1997, Science.
[96] S. Schwartz,et al. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. , 2001, Cancer research.
[97] G. Enders. Expanded Roles for Chk1 in Genome Maintenance* , 2008, Journal of Biological Chemistry.
[98] G. Zachos,et al. Chk1‐deficient tumour cells are viable but exhibit multiple checkpoint and survival defects , 2003, The EMBO journal.
[99] K. Helin,et al. NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint , 2009, Nature Cell Biology.
[100] M. Donzelli,et al. Regulating mammalian checkpoints through Cdc25 inactivation , 2003, EMBO reports.
[101] L. Carrassa,et al. Unleashing Chk1 in cancer therapy , 2011, Cell cycle.